An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study

NCT02990858 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
43
Enrollment
INDUSTRY
Sponsor class

Stopped FDA required the sponsor to halt enrollment in the trial and transition participants to available therapies for the treatment of their disease. The trial was subsequently terminated once participants were transitioned.

Conditions

Interventions

Sponsor

CytoDyn, Inc.